A postdoctoral researcher position in the field of cancer nanomedicine is available in the laboratory of Emily Day, Ph.D. The candidate will develop nanoparticles for treatment of cancer, and test these nanoparticles using in vitro and in vivo models of disease.
The laboratory is located at the University of Delaware in Newark, Delaware, and is affiliated with the Department of Biomedical Engineering at the University of Delaware, as well as with the Center for Translational Cancer Research at the Helen F. Graham Cancer Center & Research Institute.
More information about the Day Laboratory is available HERE.